Biozenta has laid its foundation in year 2018 with a noble intention to provide critical care medicines at an affordable cost enabling every human being to live healthier, happier and more active life.
In short, span of time, Biozenta became a trusted name in global pharmaceutical industry as a leading manufacturer of best quality product in Oncology and critical care segment.
Biozenta is one of the leading and fastest growing pharmaceutical and life science group of companies with its presence in multiple therapy segment like Oncology/Cytotoxic and Critical Care/lifesaving medicines.
Biozenta strongly believe that research and innovation led product portfolio is the mainstay of organization. Biozenta keeps firm commitment towards quality and continuous innovation. Biozenta has established DSIR approved R&D set up for formulation as well as API to strengthen capability of innovative and research driven manufacturing facility.
Biozenta plant are equipped with state of art, WHO cGMP Certified, PICS approved, EU GMP approvable facilities located in one of the strategic pharmaceutical zone of Una, Himachal Pradesh. At an early stage, Biozenta Leadership identified the need for achieving self-sufficiency in formulation by vertically integrating its API Plant commissioned to cater API needs
Please have a glimpse on ultra-modern manufacturing facility dedicated for the production of Generic and Branded formulation in Oncology and Critical Care segment:
First
Milestone
Biozenta registered its company in Roorkee, Uttarakhand.
Second
Milestone
Started its Oncology and Critical Care manufacturing Unit at UNA, H.P.
Third
Milestone
Started manufacturing unit for General range Plant for Injectables, Lyophilized Injectables, PFS, Contrast Media and Oral Solids at UNA H.P.
Fourth
Milestone
Established, "Biogracea Medicare", a c-GMP compliant manufacturing unit for “External Preparation Drugs and Cosmetics” at UNA, H. P.
Fifth
Milestone
Started its unique RandD Lab with advanced technology for “MAB-development” (Monoclonal antibody) in Chandigarh.
Sixth
Milestone
Started its corporate office at Mohali Punjab for Business Development Activities and Regulatory Support.
Seventh
Milestone
Proudly received “PICs” approval for Oncology and General Range manufacturing Unit based at UNA, H.P.
Eighth
Milestone
Inaugurated its new “Corporate office” as “Biozenta House” in Mumbai.
Ninth
Milestone
Signed “Partnership deed with US partner for Biosimilar products” to be launched by 2024.
Tenth
Milestone
Launching into the Domestic Marketing Division" at Mohali, 2023.
Eleventh
Milestone
Inaugurated its new “Corporate office” as “Biozenta, USA”